JPRN-jRCTs031190109招募中2 期
Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A - Ascorbic acid for CMT1A
SHIOHAMA TADASHI0 个研究点目标入组 12 人开始时间: 2019年10月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 < 18age old（—）
- 性别
- All
入选标准
- •1. Children under 18 years of age with confirmed PMP22 duplication in genetic testing.
- •2. Normal data in blood examination.
- •3. Normal data in urinary analysis.
- •4. Written informed consent from the patient, or parents in case of children.
排除标准
- •1. The patient has already taken daily vitamin treatment.
- •2. When the investigator or the investigator considers it inappropriate to conduct this study safely.
研究者
相似试验
已完成
不适用
Efficacy of Vitamin C treatment for children with Charcot-Marie-Tooth disease type 1AChildren with Charcot-Marie-Tooth disease type 1ANeurological - Other human genetics and inherited disordersACTRN12606000481572The Children's Hospital at Westmead80
尚未招募
1 期
Ascorbic acid treatment for Charcot-Marie-Tooth disease type 1AJPRN-UMIN000036332Chiba University10
已完成
不适用
Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A (CMT1A) TrialISRCTN56968278Academic Medical Centre, Department of Neurology (Netherlands)12
已完成
不适用
Ascorbic Acid Treatment in CMT1A Trial.NL-OMON26033Department of Neurology Academic Medical Center, University of AmsterdamP.O.Box 22660Amsterdam, Netherlands12
进行中（未招募）
不适用
The use of vitamin C in the prevention of central venous catheter obstruction in childreRBR-4tg72tComplexo do Hospital de Clínicas da Universidade Federal do Paraná